These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19499593)

  • 1. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
    Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
    Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational flexibility of the glycosidase NagZ allows it to bind structurally diverse inhibitors to suppress β-lactam antibiotic resistance.
    Vadlamani G; Stubbs KA; Désiré J; Blériot Y; Vocadlo DJ; Mark BL
    Protein Sci; 2017 Jun; 26(6):1161-1170. PubMed ID: 28370529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
    Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
    J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase.
    Stubbs KA; Zhang N; Vocadlo DJ
    Org Biomol Chem; 2006 Mar; 4(5):839-45. PubMed ID: 16493467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
    Kim EJ; Perreira M; Thomas CJ; Hanover JA
    J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantum mechanics/molecular mechanics study of the protein-ligand interaction of two potent inhibitors of human O-GlcNAcase: PUGNAc and NAG-thiazoline.
    Lameira J; Alves CN; Moliner V; Martí S; Kanaan N; Tuñón I
    J Phys Chem B; 2008 Nov; 112(45):14260-6. PubMed ID: 18939790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active-pocket size differentiating insectile from bacterial chitinolytic β-N-acetyl-D-hexosaminidases.
    Liu T; Zhang H; Liu F; Chen L; Shen X; Yang Q
    Biochem J; 2011 Sep; 438(3):467-74. PubMed ID: 21692744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational analysis of human OGA structure in complex with PUGNAc and NAG-thiazoline derivatives.
    de Alencar NA; Sousa PR; Silva JR; Lameira J; Alves CN; Martí S; Moliner V
    J Chem Inf Model; 2012 Oct; 52(10):2775-83. PubMed ID: 22937904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa.
    Asgarali A; Stubbs KA; Oliver A; Vocadlo DJ; Mark BL
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2274-82. PubMed ID: 19273679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
    Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
    Stubbs KA; Balcewich M; Mark BL; Vocadlo DJ
    J Biol Chem; 2007 Jul; 282(29):21382-91. PubMed ID: 17439950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by nonselective inhibition of O-GlcNAcase.
    Dehennaut V; Lefebvre T
    Proteomics; 2013 Oct; 13(20):2944-6. PubMed ID: 23983178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
    Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
    EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.
    Shanmugasundaram B; Debowski AW; Dennis RJ; Davies GJ; Vocadlo DJ; Vasella A
    Chem Commun (Camb); 2006 Nov; (42):4372-4. PubMed ID: 17057847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum mechanical/molecular mechanical molecular dynamics simulation of wild-type and seven mutants of CpNagJ in complex with PUGNAc.
    Lameira J; Alves CN; Moliner V; Martí S; Castillo R; Tuñón I
    J Phys Chem B; 2010 May; 114(20):7029-36. PubMed ID: 20429600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
    Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
    J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of O-GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry.
    Perreira M; Kim EJ; Thomas CJ; Hanover JA
    Bioorg Med Chem; 2006 Feb; 14(3):837-46. PubMed ID: 16214344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of selective inhibitors of NagZ: increased susceptibility of Gram-negative bacteria to β-lactams.
    Stubbs KA; Bacik JP; Perley-Robertson GE; Whitworth GE; Gloster TM; Vocadlo DJ; Mark BL
    Chembiochem; 2013 Oct; 14(15):1973-81. PubMed ID: 24009110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.